| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysis of c-kit expression in small cell lung cancer: Prevalence and prognostic implications
|
Camps, Carlos
|
|
2006
|
52 |
3 |
p. 343-347
5 p.
|
article
|
| 2 |
A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer
|
Stinchcombe, Thomas E.
|
|
2006
|
52 |
3 |
p. 305-311
7 p.
|
article
|
| 3 |
A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, Yuh-Min
|
|
2006
|
52 |
3 |
p. 333-338
6 p.
|
article
|
| 4 |
A randomized phase II trial evaluating standard (50mg/min) versus low (10mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy
|
Cappuzzo, F.
|
|
2006
|
52 |
3 |
p. 319-325
7 p.
|
article
|
| 5 |
Contents
|
|
|
2006
|
52 |
3 |
p. v-vi
nvt p.
|
article
|
| 6 |
Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer
|
Pimentel, F.L.
|
|
2006
|
52 |
3 |
p. 365-371
7 p.
|
article
|
| 7 |
Editorial Board
|
|
|
2006
|
52 |
3 |
p. iii-
1 p.
|
article
|
| 8 |
Estimated impact of LDCT-identified stage IA non-small-cell lung cancer on screening efficacy
|
Reich, Jerome M.
|
|
2006
|
52 |
3 |
p. 265-271
7 p.
|
article
|
| 9 |
Hedgehog signaling in small-cell lung cancer: Frequent in vivo but a rare event in vitro
|
Vestergaard, Janni
|
|
2006
|
52 |
3 |
p. 281-290
10 p.
|
article
|
| 10 |
Lung cancer with chest wall involvement: Predictive factors of long-term survival after surgical resection
|
Voltolini, Luca
|
|
2006
|
52 |
3 |
p. 359-364
6 p.
|
article
|
| 11 |
Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer
|
Hsu, Chung-Ping
|
|
2006
|
52 |
3 |
p. 349-357
9 p.
|
article
|
| 12 |
[No title]
|
Garfield, D.
|
|
2006
|
52 |
3 |
p. 373-
1 p.
|
article
|
| 13 |
Peptide ligands targeting integrin α3β1 in non-small cell lung cancer
|
Lau, Derick
|
|
2006
|
52 |
3 |
p. 291-297
7 p.
|
article
|
| 14 |
Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer
|
Leighl, Natasha B.
|
|
2006
|
52 |
3 |
p. 327-332
6 p.
|
article
|
| 15 |
Primary surgery revisited in very limited small cell lung cancer: Does it have a role?
|
Sorensen, Morten
|
|
2006
|
52 |
3 |
p. 263-264
2 p.
|
article
|
| 16 |
Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age ≤65 and performance status 2
|
Weissman, Charles H.
|
|
2006
|
52 |
3 |
p. 313-317
5 p.
|
article
|
| 17 |
Results of surgery in small cell carcinoma of the lung
|
de Antonio, David Gómez
|
|
2006
|
52 |
3 |
p. 299-304
6 p.
|
article
|
| 18 |
Secondary cancers after a lung carcinoid primary: A population-based analysis
|
Cote, M.L.
|
|
2006
|
52 |
3 |
p. 273-279
7 p.
|
article
|
| 19 |
Third-line chemotherapy for small cell lung cancer
|
de Jong, Wouter K.
|
|
2006
|
52 |
3 |
p. 339-342
4 p.
|
article
|
Journal description